{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:54:31Z","timestamp":1740164071174,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070408"],"award-info":[{"award-number":["82070408"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71497-x","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T09:02:40Z","timestamp":1725354160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of elevated baseline bilirubin caused by preadmission statin use with cardiovascular prognosis in patients undergoing elective percutaneous coronary intervention"],"prefix":"10.1038","volume":"14","author":[{"given":"Yunhui","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duanbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhebin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingbo","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guosheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,3]]},"reference":[{"key":"71497_CR1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.117.308903","volume":"121","author":"P Joseph","year":"2017","unstructured":"Joseph, P. et al. Reducing the global burden of cardiovascular disease, part 1: The epidemiology and risk factors. Circ. Res. 121, 677\u2013694 (2017).","journal-title":"Circ. Res."},{"key":"71497_CR2","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/jama.2022.0358","volume":"327","author":"DL Bhatt","year":"2022","unstructured":"Bhatt, D. L., Lopes, R. D. & Harrington, R. A. Diagnosis and treatment of acute coronary syndromes: A review. JAMA 327, 662\u2013675 (2022).","journal-title":"JAMA"},{"key":"71497_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/heartjnl-2017-312755","volume":"105","author":"RK Al-Lamee","year":"2019","unstructured":"Al-Lamee, R. K., Nowbar, A. N. & Francis, D. P. Percutaneous coronary intervention for stable coronary artery disease. Heart 105, 11\u201319 (2019).","journal-title":"Heart"},{"key":"71497_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.615254","volume":"7","author":"X Zhao","year":"2020","unstructured":"Zhao, X. et al. Prognostic value of total bilirubin in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. Front. Cardiovasc. Med. 7, 615254 (2020).","journal-title":"Front. Cardiovasc. Med."},{"key":"71497_CR5","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1542\/peds.113.6.1776","volume":"113","author":"TW Sedlak","year":"2004","unstructured":"Sedlak, T. W. & Snyder, S. H. Bilirubin benefits: Cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 113, 1776\u20131782 (2004).","journal-title":"Pediatrics"},{"key":"71497_CR6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science.3029864","volume":"235","author":"R Stocker","year":"1987","unstructured":"Stocker, R., Yamamoto, Y., McDonagh, A. F., Glazer, A. N. & Ames, B. N. Bilirubin is an antioxidant of possible physiological importance. Science 235, 1043\u20131046 (1987).","journal-title":"Science"},{"key":"71497_CR7","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/tri.12278","volume":"27","author":"F B\u00f6sch","year":"2014","unstructured":"B\u00f6sch, F. et al. Bilirubin rinse of the graft ameliorates ischemia reperfusion injury in heart transplantation. Transpl. Int. 27, 504\u2013513 (2014).","journal-title":"Transpl. Int."},{"key":"71497_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fphys.2014.00053","volume":"5","author":"R Ben-Amotz","year":"2014","unstructured":"Ben-Amotz, R. et al. Intraperitoneal bilirubin administration decreases infarct area in a rat coronary ischemia\/reperfusion model. Front. Physiol. 5, 53 (2014).","journal-title":"Front. Physiol."},{"key":"71497_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2015.02.051","volume":"240","author":"MK Akboga","year":"2015","unstructured":"Akboga, M. K. et al. Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation. Atherosclerosis 240, 110\u2013114 (2015).","journal-title":"Atherosclerosis"},{"key":"71497_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/clinchem\/40.1.18","volume":"40","author":"HA Schwertner","year":"1994","unstructured":"Schwertner, H. A., Jackson, W. G. & Tolan, G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin. Chem. 40, 18\u201323 (1994).","journal-title":"Clin. Chem."},{"key":"71497_CR11","doi-asserted-by":"publisher","first-page":"E345","DOI":"10.25011\/cim.v37i5.22015","volume":"37","author":"X-J Zhang","year":"2014","unstructured":"Zhang, X.-J. et al. Serum total bilirubin and long-term outcome in patients undergoing percutaneous coronary intervention. Clin. Investig. Med. 37, E345\u2013E351 (2014).","journal-title":"Clin. Investig. Med."},{"key":"71497_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5243589","volume":"2019","author":"C Tang","year":"2019","unstructured":"Tang, C., Qian, H., Wang, D., Qiao, Y. & Yan, G. Prognostic value of serum total bilirubin after percutaneous coronary intervention in patients with acute coronary syndrome. Biomed Res. Int. 2019, 5243589 (2019).","journal-title":"Biomed Res. Int."},{"key":"71497_CR13","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.amjcard.2019.01.019","volume":"123","author":"C Xu","year":"2019","unstructured":"Xu, C. et al. Relation of direct, indirect, and total bilirubin to adverse long-term outcomes among patients with acute coronary syndrome. Am. J. Cardiol. 123, 1244\u20131248 (2019).","journal-title":"Am. J. Cardiol."},{"key":"71497_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/0003319713504820","volume":"65","author":"MG Kaya","year":"2014","unstructured":"Kaya, M. G. et al. Relation between serum total bilirubin levels and severity of coronary artery disease in patients with non-ST-segment elevation myocardial infarction. Angiology 65, 245\u2013249 (2014).","journal-title":"Angiology"},{"key":"71497_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/0003319712474948","volume":"65","author":"T Celik","year":"2014","unstructured":"Celik, T. et al. Does serum bilirubin level on admission predict TIMI flow grade and in-hospital MACE in patients with STEMI undergoing primary PCI. Angiology 65, 198\u2013204 (2014).","journal-title":"Angiology"},{"key":"71497_CR16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41569-018-0098-5","volume":"15","author":"BB Adhyaru","year":"2018","unstructured":"Adhyaru, B. B. & Jacobson, T. A. Safety and efficacy of statin therapy. Nat. Rev. Cardiol. 15, 757\u2013769 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"71497_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/00041433-200108000-00004","volume":"12","author":"AM Gotto","year":"2001","unstructured":"Gotto, A. M. & Farmer, J. A. Pleiotropic effects of statins: Do they matter?. Curr. Opin. Lipidol. 12, 391\u2013394 (2001).","journal-title":"Curr. Opin. Lipidol."},{"key":"71497_CR18","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","volume":"335","author":"FM Sacks","year":"1996","unstructured":"Sacks, F. M. et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N. Engl. J. Med. 335, 1001\u20131009 (1996).","journal-title":"N. Engl. J. Med."},{"key":"71497_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1139\/Y07-077","volume":"85","author":"L Muchova","year":"2007","unstructured":"Muchova, L. et al. Statin treatment increases formation of carbon monoxide and bilirubin in mice: A novel mechanism of in vivo antioxidant protection. Can. J. Physiol. Pharmacol. 85, 800\u2013810 (2007).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"71497_CR20","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1161\/01.CIR.0000140694.67251.9C","volume":"110","author":"T-S Lee","year":"2004","unstructured":"Lee, T.-S., Chang, C.-C., Zhu, Y. & Shyy, J. Y. J. Simvastatin induces heme oxygenase-1: A novel mechanism of vessel protection. Circulation 110, 1296\u20131302 (2004).","journal-title":"Circulation"},{"key":"71497_CR21","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/3947","volume":"4","author":"JL Platt","year":"1998","unstructured":"Platt, J. L. & Nath, K. A. Heme oxygenase: Protective gene or Trojan horse. Nat. Med. 4, 1364\u20131365 (1998).","journal-title":"Nat. Med."},{"key":"71497_CR22","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.atherosclerosis.2011.07.094","volume":"219","author":"KL Ong","year":"2011","unstructured":"Ong, K. L., Wu, B. J., Cheung, B. M., Barter, P. J. & Rye, K. A. Association of lower total bilirubin level with statin usage: The United States National Health and Nutrition Examination Survey 1999\u20132008. Atherosclerosis 219, 728\u2013733 (2011).","journal-title":"Atherosclerosis"},{"issue":"8_Suppl","key":"71497_CR23","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/S0735-1097(23)01616-9","volume":"81","author":"Y Zhu","year":"2023","unstructured":"Zhu, Y. et al. Association of elevated baseline bilirubin caused by preadmission statin use with cardiovascular prognosis in patients undergoing elective percutaneous coronary intervention. JACC 81(8_Suppl), 1172 (2023).","journal-title":"JACC"},{"key":"71497_CR24","doi-asserted-by":"publisher","first-page":"688","DOI":"10.5551\/jat.RV17035","volume":"26","author":"T Maruhashi","year":"2019","unstructured":"Maruhashi, T., Kihara, Y. & Higashi, Y. Bilirubin and endothelial function. J. Atheroscler. Thromb. 26, 688\u2013696 (2019).","journal-title":"J. Atheroscler. Thromb."},{"key":"71497_CR25","doi-asserted-by":"publisher","first-page":"H643","DOI":"10.1152\/ajpheart.2000.278.2.H643","volume":"278","author":"JE Clark","year":"2000","unstructured":"Clark, J. E. et al. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 278, H643\u2013H651 (2000).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"71497_CR26","doi-asserted-by":"publisher","first-page":"5918","DOI":"10.1073\/pnas.84.16.5918","volume":"84","author":"R Stocker","year":"1987","unstructured":"Stocker, R., Glazer, A. N. & Ames, B. N. Antioxidant activity of albumin-bound bilirubin. Proc. Natl. Acad. Sci. USA 84, 5918\u20135922 (1987).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"71497_CR27","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1096\/fj.04-2368fje","volume":"19","author":"S Lanone","year":"2005","unstructured":"Lanone, S. et al. Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: Implications for protection against endotoxic shock in rats. FASEB J. 19, 1890\u20131892 (2005).","journal-title":"FASEB J."},{"key":"71497_CR28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0167-4838(91)90478-I","volume":"1076","author":"JY Kwak","year":"1991","unstructured":"Kwak, J. Y., Takeshige, K., Cheung, B. S. & Minakami, S. Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil cell-free system. Biochim. Biophys. Acta 1076, 369\u2013373 (1991).","journal-title":"Biochim. Biophys. Acta"},{"key":"71497_CR29","doi-asserted-by":"publisher","first-page":"16712","DOI":"10.1016\/S0021-9258(19)89449-8","volume":"269","author":"J Neuzil","year":"1994","unstructured":"Neuzil, J. & Stocker, R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J. Biol. Chem. 269, 16712\u201316719 (1994).","journal-title":"J. Biol. Chem."},{"key":"71497_CR30","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/0006-2952(95)02395-X","volume":"51","author":"TW Wu","year":"1996","unstructured":"Wu, T. W., Fung, K. P., Wu, J., Yang, C. C. & Weisel, R. D. Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem. Pharmacol. 51, 859\u2013862 (1996).","journal-title":"Biochem. Pharmacol."},{"key":"71497_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fphar.2012.00048","volume":"3","author":"KJ Peyton","year":"2012","unstructured":"Peyton, K. J. et al. Bilirubin inhibits neointima formation and vascular smooth muscle cell proliferation and migration. Front. Pharmacol. 3, 48 (2012).","journal-title":"Front. Pharmacol."},{"key":"71497_CR32","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1161\/STROKEAHA.109.560649","volume":"40","author":"H Kimm","year":"2009","unstructured":"Kimm, H., Yun, J. E., Jo, J. & Jee, S. H. Low serum bilirubin level as an independent predictor of stroke incidence: A prospective study in Korean men and women. Stroke 40, 3422\u20133427 (2009).","journal-title":"Stroke"},{"key":"71497_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1161\/ATVBAHA.107.153262","volume":"28","author":"TS Perlstein","year":"2008","unstructured":"Perlstein, T. S., Pande, R. L., Beckman, J. A. & Creager, M. A. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler. Thromb. Vasc. Biol. 28, 166\u2013172 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"71497_CR34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3858\/emm.2010.42.11.075","volume":"42","author":"H Zhu","year":"2010","unstructured":"Zhu, H. et al. Bilirubin protects grafts against nonspecific inflammation-induced injury in syngeneic intraportal islet transplantation. Exp. Mol. Med. 42, 739\u2013748 (2010).","journal-title":"Exp. Mol. Med."},{"key":"71497_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.repc.2018.08.008","volume":"38","author":"I Rencuzogullari","year":"2019","unstructured":"Rencuzogullari, I. et al. Assessment of the relationship between preprocedural C-reactive protein\/albumin ratio and stent restenosis in patients with ST-segment elevation myocardial infarction. Rev. Port. Cardiol. (Engl Ed) 38, 269\u2013277 (2019).","journal-title":"Rev. Port. Cardiol. (Engl Ed)"},{"key":"71497_CR36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/MCA.0000000000001271","volume":"34","author":"M Karakayali","year":"2023","unstructured":"Karakayali, M. et al. The prognostic value of HALP score in predicting in-hospital mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coron. Artery Dis. 34, 483\u2013488 (2023).","journal-title":"Coron. Artery Dis."},{"key":"71497_CR37","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.amjcard.2012.09.011","volume":"111","author":"M Gul","year":"2013","unstructured":"Gul, M. et al. Prognostic value of total bilirubin in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. Am. J. Cardiol. 111, 166\u2013171 (2013).","journal-title":"Am. J. Cardiol."},{"key":"71497_CR38","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1097\/SMJ.0b013e3181eac06a","volume":"103","author":"K Okuhara","year":"2010","unstructured":"Okuhara, K. et al. Change in bilirubin level following acute myocardial infarction is an index for heme oxygenase activation. South Med. J. 103, 876\u2013881 (2010).","journal-title":"South Med. J."},{"key":"71497_CR39","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/nmo.12404","volume":"26","author":"AE Bharucha","year":"2014","unstructured":"Bharucha, A. E. et al. Effects of aspirin and simvastatin and aspirin, simvastatin, and lipoic acid on heme oxygenase-1 in healthy human subjects. Neurogastroenterol. Motil. 26, 1437\u20131442 (2014).","journal-title":"Neurogastroenterol. Motil."},{"key":"71497_CR40","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.atherosclerosis.2012.06.002","volume":"223","author":"M Hu","year":"2012","unstructured":"Hu, M. & Tomlinson, B. Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia. Atherosclerosis 223, 427\u2013432 (2012).","journal-title":"Atherosclerosis"},{"key":"71497_CR41","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.mehy.2006.12.069","volume":"69","author":"MF McCarty","year":"2007","unstructured":"McCarty, M. F. \u201cIatrogenic Gilbert syndrome\u201d\u2014a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin. Med. Hypotheses 69, 974\u2013994 (2007).","journal-title":"Med. Hypotheses"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71497-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71497-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71497-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T13:11:39Z","timestamp":1725628299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71497-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71497"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71497-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2024,9,3]]},"assertion":[{"value":"25 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee of Sir Run Run Shaw Hospital of Zhejiang University. (20201217-36).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"20451"}}